On June 26, Bayer AG announced new steps it is taking to resolve the thousands of lawsuits linked to Monsanto’s glyphosate-based weed killer Roundup. Today there are over 14,000 pending lawsuits against Bayer-owned Monsanto alleging Roundup caused heavily exposed users cancer. More specifically, the lawsuits…
Roundup, which is a product of Bayer-owned Monsanto, is the most popular weed killer in the world. It is used on nearly all cotton, corn, and soy farms in the United States and on individual consumers’ personal properties. Despite the product’s worldwide popularity, however, recent…
As consumers of modern medicine, we rely on the Food and Drug Administration (FDA) to inform us of the risks and complications associated with medical drugs and devices on the market. Unfortunately, this is often not the case. A recent Kaiser Health News investigation revealed…
Recently, a federal jury ordered Monsanto to pay $80 million to 70-year-old Edwin Hardeman, who got diagnosed with cancer after using their weed killer for 26 years. The weed killer in question, Roundup, is a glyphosate-based herbicide that Hardeman regularly used on his 56-acre property…
Recently, a federal jury in Indianapolis awarded $3 million to a woman who had serious medical complications caused by a defective inferior vena cava (IVC) filter. This verdict is noteworthy because it is the first bellwether trial to result in a win for the injured…
With thousands of reported side effects, the blood thinning drug Xarelto has been controversial since its initial approval for medical use in 2011. Nevertheless, Johnson & Johnson (J&J) submitted a Supplemental New Drug Application on Dec. 14 for Xarelto to be used as a preventative…
The FDA recently issued a warning dissuading customers from using Rhino male sexual enhancement products, which are unregulated supplements typically found for sale at gas stations and convenience stores. This warning comes after the discovery that many Rhino supplements contain unlisted ingredients that could cause…
Starting in July of this year, the U.S. Food & Drug Administration (FDA) began issuing a series of recalls for heart medication valsartan—most due to entire batches of the drug testing positive for N-Nitrosodiethylamine (NDEA), a chemical that can lead to liver damage, tumors and,…
You might be familiar with Pradaxa—a blood-thinning medication that is used to prevent blood clots and strokes in heart arrhythmia patients and manufactured by Boehringer Ingelheim Pharmaceuticals Incorporated (BIPI). What you might not be aware of are the claims that their product marketing was misleading…
In July, the Food and Drug Administration (FDA) issued a voluntary recall of multiple medications containing valsartan that were manufactured by the Chinese pharmaceutical company, Zhejiang Huahai. The recall occurred after two likely carcinogenic chemicals, N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), were detected in the product—a…
